Navigation Links
Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET

AUSTIN, Texas, April 24, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, will hold a conference call on Tuesday, May 15, 2012 at 4:30 p.m. Eastern time to discuss results for the first quarter ended March 31, 2012. Financial results will be issued in a press release prior to the call.

Vermillion management will host the call, followed by a question and answer period.

Date: Tuesday, May 15, 2012
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Dial-In Number: 1-800-268-5851
International: 1-303-223-2680
Conference ID#: 21589040

The conference call will be broadcast simultaneously here and available for replay via the investor section of the company's Web site at

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.

A replay of the call will be available approximately two hours after the call and until May 29, 2012.

Toll-free replay number: 1-800-633-8284
International replay number: 1-402-977-9140
Replay pin number: 21589040

About Vermillion
Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Additional information about Vermillion can be found at

Investor Relations:
Liolios Group, Inc.
Ron Both
Tel 949-574-3860



SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vermillion to Report Preliminary Results for Fourth Quarter and Fiscal Year 2011 on February 23, 2012
2. Vermillion Completes the Acquisition of Correlogic Systems Ovarian Cancer Diagnostics Business
3. Vermillion Reports Results for Third Quarter 2011
4. Vermillion to Present at Stephens Fall Investment Conference on November 16, 2011
5. Vermillion Engages Liolios Group to Lead Investor Relations Program
6. Vermillion Enhances Management Team With A Key Addition
7. Vermillion Appoints Distribution Partner for OVA1® in Israel and the Palestine Territories
8. Vermillion Reports Financial Results for the First Quarter 2011
9. Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test
10. Vermillion Attends 42nd Annual Meeting of the Society of Gynecologic Oncologists
11. Vermillion to Present at the Roth 23rd Annual OC Growth Stock Conference March 13-16, 2011, Laguna Niguel, CA
Post Your Comments:
(Date:12/1/2015)... -- ) has announced ... Disposables Market by product, by Animal - Global ... --> ) has announced the ... Market by product, by Animal - Global Forecast ... --> Research and Markets ( ) ...
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)...  The migration to value-based care will require ... that help patients stay healthy and reduce healthcare ... enabled, incorporate care guidelines and be reflective of ... also allow all stakeholders to collaborate across care ... That is the vision, however, research by Chilmark ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical ... U.S. and is the only hospital in the region providing what is known ... of transcatheter pacing patients were revealed recently at a medical conference and published ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Growth ... in part due to decreases in utilization of hospital and nonhospital care, according to ... CompScope™ Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim ...
(Date:12/1/2015)... ... ... It’s official: Tattoo taboo is a thing of the past. One in ... whopping one in three aged 18 to 25 is inked). As tattoos transition to ... In fact, RealSelf , the world’s largest community for learning and sharing information ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... radiographic technicians must mark the film for accurate interpretation by the radiologist. The ... Fortunately, an inventor from Sacramento, Calif., has found a way to alleviate this ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare ... IT Healthcare was recognized as a finalist in the category of Digital Solutions ...
Breaking Medicine News(10 mins):